Ignite Creation Date:
2024-05-06 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 12:54 PM
Study NCT ID:
NCT03677011
Status:
COMPLETED
Last Update Posted:
2022-04-06
First Post:
2018-07-25
Brief Title:
Andrositol TEST as Diagnostic Assay to Predict the Fertilization Potential in IVF
Sponsor:
LoLiPharma srl
Organization:
LoLiPharma srl
Study Overview
Official Title:
Andrositol TEST as Diagnostic Assay to Predict the Fertilization Potential of the Sperm in the in Vitro Fertilization IVF Procedures
Status:
COMPLETED
Status Verified Date:
2022-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Andrositol test allows to obtain additional information besides the WHO parameters and to evaluate the semen energetic status The diagnosis is performed by analyzing the semen at two different time points before the treatment and 30 after the addiction of myo-inositol directly to the semen The purpose of this study is to evaluate if the responsiveness to the Andrositol test of a sperm sample can be predictive of its fertilization rate in an ICSI Intracytoplasmic Sperm Injection cycle primary outcome Secondary outcomes as embryo development embryo euploidy status and embryo implantation rate will be evaluated
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None